Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Ublituximab
Trade Name
Synonyms LFB-R603|TG-1101|TG-20|TGTX-1101
Drug Descriptions

Ublituximab (TG-1101) is a monoclonal antibody that targets CD20 that may induce complement-dependent and antibody-dependent cell-mediated cytotoxicity against B-cells expressing CD20, potentially resulting in increased B-cell death (PMID: 23611989, PMID: 32351164).

DrugClasses CD20 Antibody 11

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Ibrutinib + Ublituximab Ibrutinib Ublituximab 0 1
Ibrutinib + Ublituximab + Umbralisib Ibrutinib Ublituximab Umbralisib 1 1
Pembrolizumab + Ublituximab + Umbralisib Pembrolizumab Ublituximab Umbralisib 0 1
Ublituximab Ublituximab 0 2
Ublituximab + Umbralisib Ublituximab Umbralisib 3 7
Ublituximab + Umbralisib + Venetoclax Ublituximab Umbralisib Venetoclax 0 3


Additional content available in CKB BOOST